This is a routine, tax-driven sale following equity vesting and not an indicator of negative sentiment. Traders should monitor for actual execution of the sale and compare with insider buying patterns, but no immediate action is warranted.
ZLAB drugs
ZLAB drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Apr 6 $20.50entry
- T+1 · 7mo ago +2.44%α +2.38% · $21.00
- T+5 · 7mo ago +4.10%α −0.04% · $21.34
- T+20 · due 7mo ago Pending
- T+60 · due 5mo ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Rafael Amado, an officer of Zai Lab, filed a Form 144 to notify intent to sell 2,739 American Depositary Shares (ADS) valued at approximately $307,141. The shares are being sold following a restricted stock vesting event, with part of the proceeds used to cover tax obligations from the vesting.
Key Facts
- Rafael Amado, an officer, intends to sell 2,739 ADSs of Zai Lab.
- The sale is related to a restricted stock vesting event on April 2, 2026.
- Proceeds will cover tax obligations arising from the vesting and settlement of equity awards.
- Total value of the proposed sale is $307,141 based on recent market price.
- This follows prior small sales by Amado in March and early April 2026 totaling ~$231,000.
Financial Impact
Approximately $307,141 in shares proposed for sale, representing a routine post-vesting tax-related disposition.
Risk Factors
- Perception of insider selling could weigh on sentiment if misinterpreted by retail investors.
- Repeated sales by the same insider may signal reduced confidence if not properly contextualized.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-002785 |
| Document: 0001959173-26-002785-index.html | 0001959173-26-002785 |
| Document: 0001959173-26-002785.txt | 0001959173-26-002785 |
Track record
23 reports on ZLAB
3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.13% at T+20 after the May 7, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $22.60 to $25.48 Now $23.47 +3.85% ▲ +12.74% +12.43% vs SPY
- Oct 23, 202624d ago 8-K Bullish 6/10 Entry $24.03 to $24.34 Now $23.47 −2.33% ▲ +1.29% +0.58% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $25.64 to $26.17 Now $23.47 −8.46% ▲ +2.07% +1.75% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 12, 202613w ago 144 Neutral 2/10 Entry $25.49 to $26.03 Now $23.47 −7.92% ▲ +2.12% +1.42% vs SPY
- Jul 1, 202619w ago Insider Cluster Neutral 2/10 Entry $19.12 to $19.08 Now $23.47 +22.75% ▼ −0.21% −1.08% vs SPY
- Jun 29, 202620w ago Insider Cluster Neutral 3/10 Entry $19.00 to $19.15 Now $23.47 +23.53% ▲ +0.79% +0.92% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 5/10 Entry $17.64 to $17.07 Now $23.47 −33.05% ▲ +3.23% +3.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers